ARQL's Related News

Sabre Corp., L Brands Dip into Friday’s 52-Week Low Club

     Fri, 17 Feb 2017 17:04:40 EST


ARQULE INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits

     Fri, 17 Feb 2017 08:31:18 EST


6:02 am ArQule and Daiichi Sankyo (<a href="/q?s=dsnky" name="dsnky">DSNKY</a>) announce the METIV-HCC phase 3 study of tivantinib in hepatocellular carcinoma did not meet its primary endpoint of improving overall survival

     Fri, 17 Feb 2017 07:02:00 EST


Daiichi Sankyo and ArQule Announce the Completion of the METIV-HCC Phase 3 Study of Tivantinib in Second-Line Treatment of MET-Overexpressing Hepatocellular Carcinoma

Business Wire      Fri, 17 Feb 2017 07:00:00 EST


Daiichi Sankyo and ArQule Announce the Completion of the METIV-HCC Phase 3 Study of Tivantinib in Second-Line Treatment of MET-Overexpressing Hepatocellular Carcinoma

     Fri, 17 Feb 2017 07:00:00 EST


Daiichi Sankyo and ArQule Announce the Completion of the METIV-HCC Phase 3 Study of Tivantinib in Second-Line Treatment of MET-Overexpressing Hepatocellular Carcinoma

Business Wire      Fri, 17 Feb 2017 07:00:00 EST


ArQule to Present at The Leerink Partners 6th Annual Global Healthcare Conference on February 15, 2017

Business Wire      Wed, 08 Feb 2017 08:00:00 EST


ArQule (ARQL) Catches Eye: Stock Moves 7.2% Higher

     Fri, 13 Jan 2017 09:00:01 EST


ARQULE INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation

     Tue, 10 Jan 2017 08:31:29 EST


ETFs with exposure to ArQule, Inc. : December 21, 2016

     Wed, 21 Dec 2016 12:58:27 EST


How ArQule, Inc. (ARQL) Stacks Up Against Its Peers

     Tue, 20 Dec 2016 15:02:40 EST


Data on Proprietary BTK Inhibitor, ARQ 531, Demonstrating Inhibition of Wild Type and C481S Mutant BTK and Superiority to Ibrutinib in TCL1 Mouse Model Presented at the American Society of Hematology Annual Meeting

Business Wire      Sun, 04 Dec 2016 22:00:00 EST


Preclinical Data on Proprietary AKT Inhibitor, ARQ 092, Demonstrating Effectiveness in the Treatment of Sickle Cell Disease Presented at the American Society of Hematology Annual Meeting

Business Wire      Sat, 03 Dec 2016 18:45:00 EST


ARQULE INC Financials

     Wed, 16 Nov 2016 14:04:12 EST


Could Trump Tax Cut Plans, Republican Congress Spur Biotech M&A?

     Thu, 10 Nov 2016 17:01:53 EST


ArQule, Inc. :ARQL-US: Earnings Analysis: Q3, 2016 By the Numbers : November 8, 2016

     Tue, 08 Nov 2016 12:00:31 EST


Edited Transcript of ARQL earnings conference call or presentation 7-Nov-16 2:00pm GMT

     Mon, 07 Nov 2016 13:48:41 EST


ARQULE INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits

     Mon, 07 Nov 2016 09:01:07 EST


ArQule Reports Third Quarter 2016 Financial Results

Business Wire      Mon, 07 Nov 2016 08:00:00 EST


Advancements in ArQule’s Proprietary Pipeline to be Highlighted at the 2016 American Society of Hematology Annual Meeting

Business Wire      Thu, 03 Nov 2016 09:05:00 EST


Top10 Market Gainers

Last update: 08:50 PM, Feb 17

# Name Last Change Percent
1 GLDG 0.1 0.0997 33233.33%
2 HYHY 0.0001 9.9e-05 9900.00%
3 SGLRF 0.001 0.0009 900.00%
4 DTRO 0.00107 0.00087 435.00%
5 WRFXD 0.13 0.1045 409.80%
6 PUDA 0.001 0.0008 400.00%
7 VSTR 0.0024 0.0016 200.00%
8 STLK 0.0003 0.0002 200.00%
9 FPFI 0.0003 0.0002 200.00%
10 LKOLF 0.0003 0.0002 200.00%

Top10 Market Decliners

Last update: 08:50 PM, Feb 17

# Name Last Change Percent
1 HLXW 1e-06 -9.9e-05 -99.00%
2 NEOM 1e-06 -9.9e-05 -99.00%
3 EKWX 1e-06 -9.9e-05 -99.00%
4 CKYS 1e-06 -9.9e-05 -99.00%
5 PEFF 0.02 -0.2541 -92.70%
6 CTLE 1e-05 -9e-05 -90.00%
7 ENTI 1e-05 -9e-05 -90.00%
8 DNAG 1e-05 -9e-05 -90.00%
9 NSLPQ 0.0001 -0.0009 -90.00%
10 CNAB 0.205373 -1.794627 -89.73%

Top10 Market Gainers

Last update: 08:50 PM, Feb 17

# Name Last Change Percent
1 SNBN 12.82 4.67 57.30%
2 MOSY 3.43 1.16 51.10%
3 LMIA 13.61 4.42 48.10%
4 CYCC 6.74 1.69 33.47%
5 CNBX 3.89 0.96 32.76%
6 TGOPY 6.0 1.35 29.03%
7 SGLBW 1.25 0.25 25.00%
8 GSIT 7.08 1.36 23.78%
9 BTUUQ 2.19 0.38 20.99%
10 BLPH 1.08 0.1699 18.67%

Top10 Market Decliners

Last update: 08:50 PM, Feb 17

# Name Last Change Percent
1 XTLB 2.34 -1.2401 -34.64%
2 XGTIW 9.26 -4.116 -30.77%
3 MJMD 7.0 -2.0 -22.22%
4 DRYS 3.45 -0.9 -20.69%
5 TEUCF 4.0 -1.0 -20.00%
6 PME 3.5 -0.83 -19.17%
7 HTCO 3.58 -0.84 -19.00%
8 ARQL 1.2 -0.27 -18.37%
9 CRGS 1.29 -0.26 -16.77%
10 KODK.WS.A 1.76 -0.3517 -16.65%

Top10 Market Gainers

Last update: 08:50 PM, Feb 17

# Name Last Change Percent
1 IALB 66.1 26.2 65.66%
2 SNBN 12.82 4.67 57.30%
3 LMIA 13.61 4.42 48.10%
4 AAPC 25.6232 7.6232 42.35%
5 CYCC 6.74 1.69 33.47%
6 IFMK 21.8 5.06 30.23%
7 TGOPY 6.0 1.35 29.03%
8 DGI 36.8 7.2 24.32%
9 GSIT 7.08 1.36 23.78%
10 ATRI 577.0 106.0 22.51%

Top10 Market Decliners

Last update: 08:50 PM, Feb 17

# Name Last Change Percent
1 FOXF 27.0 -1.0 -100.00%
2 XGTIW 9.26 -4.116 -30.77%
3 MJMD 7.0 -2.0 -22.22%
4 CIR 61.55 -10.25 -14.28%
5 NUS 48.0 -7.14 -12.95%
6 AMBR 8.11 -1.2 -12.89%
7 ORC 10.83 -1.56 -12.59%
8 JANL 11.0 -1.5 -12.00%
9 PI 31.2 -4.16 -11.76%
10 TOSYY 9.545 -1.085 -10.21%

Top10 Market Gainers

Last update: 08:50 PM, Feb 17

# Name Last Change Percent
1 IALB 66.1 26.2 65.66%
2 DGI 36.8 7.2 24.32%
3 ATRI 577.0 106.0 22.51%
4 ANET 119.0 18.83 18.80%
5 UEIC 72.65 9.55 15.13%
6 UN 48.44 6.12 14.46%
7 UL 48.47 5.9 13.86%
8 KEFI 175.0 20.0 12.90%
9 KHC 96.33 9.05 10.37%
10 MCRAA 32.0 3.0 10.34%

Top10 Market Decliners

Last update: 08:50 PM, Feb 17

# Name Last Change Percent
1 CIR 61.55 -10.25 -14.28%
2 NUS 48.0 -7.14 -12.95%
3 PI 31.2 -4.16 -11.76%
4 DIN 60.0 -6.55 -9.84%
5 ROCK 40.3 -4.0 -9.03%
6 HOFD 43.0 -3.89 -8.30%
7 VOPKY 41.19 -3.525 -7.88%
8 MTRN 35.85 -2.7 -7.00%
9 NPPXF 37.81 -2.82 -6.94%
10 SATS 51.0 -3.5 -6.42%